Optimal nadir PSA after salvage cryotherapy for radiorecurrent prostate cancer

According to a new article in the Journal of Endourology, the authors have identified an optimal PSA nadir level after whole-gland salvage prostate cryoablation among patients with recurrent prostate cancer. … READ MORE …

Salvage whole-gland cryoablation after failure of primary radiation therapy

After last Tuesday’s post on focal salvage therapy for management of radiorecurrent disease, we now have long-term data on the use of salvage whole-gland cryoablation in the same category of patients. … READ MORE …

Focal salvage therapy for treatment of radiorecurrent prostate cancer

A new paper in the World Journal of Urology has reviewed the available evidence that focal forms of salvage therapy may be usable in men with biochemically recurrent prostate cancer after first-line radiation therapy (“radiorecurrent” prostate cancer). … READ MORE …

Current options for treatment of radiorecurrent, localized prostate cancer

For men who choose to have radiotherapy (external photon beam, external proton beam, or brachytherapy of some type) as first-line therapy for localized prostate cancer, a major issue is, “What if the cancer recurs after treatment?” … READ MORE …